Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome

BACKGROUND: Gut microbiota alterations including small intestinal bacterial overgrowth (SIBO) might play a role in pathogenesis of irritable bowel syndrome (IBS). Rifaximin could effectively and safely improve IBS symptoms. The aim of this study was to investigate the effect of rifaximin on Gastroin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Xiaojun, Tian, Zhenyi, Luo, Mei, Xiong, Lishou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291629/
https://www.ncbi.nlm.nih.gov/pubmed/32532214
http://dx.doi.org/10.1186/s12876-020-01336-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291629/
https://www.ncbi.nlm.nih.gov/pubmed/32532214
http://dx.doi.org/10.1186/s12876-020-01336-6

Ejemplares similares